Investors and M&A
Technical-Commercial Due Diligence for Technology-Driven Investments and Acquisitions
We support private equity, venture capital, strategic buyers and corporate M&A teams in assessing the technologies, operations, markets and commercial risks behind investment and acquisition decisions.
Our work combines scientific and technical depth with commercial perspective, helping investors understand not only whether a technology works, but whether it can scale, compete and support the investment thesis.
Private Equity
Venture Capital
Strategic Buyers
Corporate M&A
Where We Support Investors
We provide independent technical-commercial assessment across the investment process, from early opportunity screening to detailed due diligence and post-investment value creation.
Technology Assessment
Technology maturity
Differentiation
Technical feasibility
Development roadmap
Critical dependencies
Technology risk
Manufacturing & Scale-Up
Process robustness
Production capability
Scale-up readiness
CapEx requirements
Supplier dependencies
Operational constraints
Commercial Assessment
Market attractiveness
Customer adoption
Competitive position
Pricing
Business model
Commercial readiness
Investment Case
Material risks
Critical assumptions
Mitigation requirements
Growth implications
Capital requirements
Investment-thesis implications
Who We Support
Private Equity
Supporting platform investments, add-on acquisitions and technology-driven businesses where manufacturing capability, process robustness, technical dependencies and scalability materially affect the Investment Implications.
Venture Capital & Growth
Assessing scientific differentiation, technical feasibility, development risk, commercial readiness, market potential and scalability in science- and technology-driven ventures.
Strategic Buyers & Corporate M&A
Evaluating technology fit, strategic relevance, portfolio complementarity, integration risk and make/buy/partner decisions.
Selected Investor Engagement
Pre-Acquisition Technology & Scale-Up Assessment for a Private Equity Investor
An institutional investor was evaluating the acquisition of a growth-stage advanced-materials company and required an independent assessment of whether laboratory-stage technology and supporting technical documentation provided a credible basis for commercial-scale production.
The assessment focused on scale-up assumptions, process robustness, technical dependencies and key risks relevant to the investment decision.
The work provided an additional evidence base for the investment committee's evaluation of the proposed multi-million-euro transaction.
View Case Study
Sectors
Life Sciences & Biotechnology
MedTech & Diagnostics
Life-Science Tools
Advanced Materials
Specialty Chemicals
Industrial & Manufacturing Technologies
Deep Tech
Sustainable & Circular Technologies
Why Work With Us?
We go beyond identifying technical issues. We assess how technology, manufacturing and operational risks may affect scalability, market potential, capital requirements and ultimately the investment thesis.
Scientific Depth
Understand the science and technology behind the investment.
Commercial Perspective
Connect technical findings with markets, customers, competitive positioning and growth.
Direct Senior Involvement
Clients work directly with Dr. Maziar Matloubi throughout the engagement.
Specialist Network
Additional technical and industry expertise can be brought in when required.
Considering an Investment or Acquisition?
If technology, manufacturing, scalability or commercial readiness is material to the investment case, we would be pleased to discuss where independent technical-commercial assessment could add clarity to your diligence process.